DHR Danaher Corporation
USHealthcareAs of 2026-08-24
Why DHR matters now
Danaher Corporation (DHR) is a US stock in Healthcare. The latest InvestLog snapshot shows $215.16 with -1.69% on the session and $151.25B in market capitalization; recent performance reads 1-month +6.06% and YTD -22.61%.
The latest financial table shown here is Q1 2026, with revenue of $5.95B, net income of $1.03B, and EPS of $1.45. Investors can compare that operating picture with valuation signals such as P/E 37.10 and FCF yield 4.2%.
InvestLog's latest related AI research is a Insider Sale note titled "Blair Rainer sells $12.7M of DHR". The latest indexable market news headline is "Ally Financial Inc. Invests $8.95 Million in Danaher Corporation DHR" from Defense World.
Additional event context on this page matters because analyst consensus is Buy with a median target of $230.00; recent insider activity includes Lamanna Charles W filing A-Award; recent congressional disclosure data includes Michael McCaul Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
37.10
PEG
—
P/B
2.37
P/S
5.06
EV/EBITDA
20.80
DCF Value
$223.00
FCF Yield
4.2%
Div Yield
0.8%
Margins & Returns
Gross Margin
60.7%
Operating Margin
21.0%
Net Margin
14.9%
ROE
7.1%
ROA
4.4%
ROIC
5.7%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $5.95B | $1.03B | $1.45 |
| Q4 2025 | $6.84B | $1.20B | $1.68 |
| FY 2025 | $24.57B | $3.61B | $5.04 |
| Q3 2025 | $6.05B | $908.0M | $1.27 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$230.89
Target (Median)
$230.00
Target Range
$200.00 - $265.00
Trading Activity
Insider Trades
Congress Trades
Related AI Research
Blair Rainer sells $12.7M of DHRBlair Rainer 内部减持 丹纳赫公司 (DHR) $12.7M
Danaher Corporation (ticker: DHR) President and CEO Blair Rainer sold 58,255 shares of common stock via open-market transaction on August 21, 2026, generating total proceeds of $12,736,095.丹纳赫公司(股票代码DHR)总裁兼首席执行官Blair Rainer于2026年8月21日通过公开场内交易出售58,255股公司普通股,交易总价值达12,736,095美元,相关内幕交易Form 4备案于2026年8月24日提交至美国证券交易委员会(SEC)。该笔交易价值占公司当前1513亿美元总市值的0.008%,属于相对公司整体规模的小额持仓调整,市场参与者可通过该备案追踪高管公开交易行为。
DANAHER CORP /DE/ files 8-K Item 5.02 executive-change disclosure丹纳赫公司 (DHR) 提交 8-K Item 5.02 高管变动披露
On August 3, 2026, Danaher Corporation (NYSE: DHR) filed an 8-K form with the SEC (filing link: Per Item 5.2026年8月3日,丹纳赫公司(NYSE: DHR)向美国SEC提交8-K备案文件(备案链接: 5.02的披露要求,正式任命Julie Sawyer Montgomery为公司总裁兼首席执行官,任职生效日期为2026年10月1日。该备案于当日16:27:19被SEC正式接收,这一治理层面的披露是投资者评估这家多元化科技与医疗公司领导层稳定性及战略延续性的核心参考依据。
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
—
Beta
0.83
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.